B of A Securities Upgrades Apollo Medical Hlgs to Buy, Raises Price Target to $55
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Adam Ron upgrades Apollo Medical Holdings (AMEH) from Neutral to Buy and increases the price target from $44 to $55.

February 22, 2024 | 2:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Apollo Medical Holdings was upgraded from Neutral to Buy by B of A Securities analyst Adam Ron, with the price target raised from $44 to $55.
Upgrades by analysts, especially from neutral to buy ratings, typically signal a positive outlook on the stock, suggesting potential for price appreciation. The increase in price target further supports this positive sentiment, indicating an expectation of higher future stock prices. Given the direct impact of such analyst actions on investor perceptions and potential market reactions, this upgrade and price target increase are likely to have a positive short-term impact on AMEH's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100